Vanguard FTSE Dev All Cap ex North America Index ETF CAD Hdgd News - VI

Encysive Pharmaceuticals Inc- (25-NSE)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION...

Pfizer Completes Acquisition of Encysive Pharmaceuticals Inc.

Pfizer Inc (NYSE:PFE) today announced that it has completed the acquisition of all remaining outstanding shares of common stock...

Encysive Pharmaceuticals Inc - Quarterly Report (10-Q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ...

Encysive Pharmaceuticals Inc - Schedule 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment...

Encysive Pharmaceuticals Inc - Tender offer statement by Issuer (SC TO-I)

Table of Contents SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE TO (Rule 14d-100) TENDER OFFER...

Encysive Pharmaceuticals Inc - Information Statement - Merger or Acquisition (preliminary) (PREM14C)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ...

Encysive Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (SC 13D/A)

...

Encysive Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (RULE 14d-101) SOLICITATION/RECOMMENDATION...

Encysive Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO/A Tender Offer Statement under Section 14(d)(1) or...

Encysive Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 ENCYSIVE...

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Encysive Pharmaceuticals Inc - Schedule 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment...

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Encysive Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)

Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (RULE 14d-101...

Encysive Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO/A Tender Offer Statement under Section 14(d)(1) or...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Vanguard FTSE Dev All Cap ex North America Index ETF CAD Hdgd (VI)

Empower your portfolio: Real-time discussions and actionable trading ideas.

VI News

Encysive Pharmaceuticals Inc- (25-NSE)

Pfizer Completes Acquisition of Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Inc - Quarterly Report (10-Q)

Encysive Pharmaceuticals Inc - Schedule 13G

Encysive Pharmaceuticals Inc - Tender offer statement by Issuer (SC TO-I)

Encysive Pharmaceuticals Inc - Information Statement - Merger or Acquisition (preliminary) (PREM14C)

Encysive Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (SC 13D/A)

Encysive Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)

Encysive Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)

Encysive Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D)

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

Encysive Pharmaceuticals Inc - Schedule 13G

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

Encysive Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)

Encysive Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)

VI Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Vanguard FTSE Dev All Cap ex North America Index ETF CAD Hdgd (VI) News

Vanguard FTSE Dev All Cap ex North America Index ETF CAD Hdgd (VI)

Empower your portfolio: Real-time discussions and actionable trading ideas.

VI News

Encysive Pharmaceuticals Inc- (25-NSE)

Pfizer Completes Acquisition of Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Inc - Quarterly Report (10-Q)

Encysive Pharmaceuticals Inc - Schedule 13G

Encysive Pharmaceuticals Inc - Tender offer statement by Issuer (SC TO-I)

Encysive Pharmaceuticals Inc - Information Statement - Merger or Acquisition (preliminary) (PREM14C)

Encysive Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (SC 13D/A)

Encysive Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)

Encysive Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)

Encysive Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D)

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

Encysive Pharmaceuticals Inc - Schedule 13G

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

Encysive Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)

Encysive Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)

VI Discussion

Your Recent History